Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-05

Clinical Trial Update: A Prospective Real World Study of Rimegepant in the Treatment of Migraine

View source ↗

Summary

This clinical trial update notes the completion of a prospective real-world study evaluating rimegepant for the treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rimegepant (rimegepant)

Snippet

Sponsor: Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine | Conditions: Migraine | Status: COMPLETED